Skip to main content
Premium Trial:

Request an Annual Quote

HistoRx Raises $1.5M in Series A Financing

NEW YORK, Sept. 14 (GenomeWeb News) - HistoRx, a provider of imaging technology for tissue and tissue microarrays, has raised $1.5 million in a Series A financing round, the company said today.

 

HistoRx, based in New Haven, Conn., exclusively licenses the imaging technology from YaleUniversity, where it was developed by David Rimm and Robert Camp. The technology allows users to measure protein expression in subcellular compartments automatically. The company also holds an exclusive license to patient cohort databases from Yale's tissue archive containing clinical follow-up information corresponding to different types of human cancer.

 

HistoRx provides contract services to academic institutions and companies and licenses its technology to selected laboratories.

 

Navigator Technology Ventures led the investment round, which also included Genentech, Sachem Ventures, and Marnat Investments.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.